Indivior Pharmaceuticals, Inc. (INDV) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the IndiVS second quarter 2025 Results Conference call and webcast. At this time all participants are in a listen-only mode. After the speaker's presentation there will be a question and answer session. To ask a question during the session please press star 1 and 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question please press star 1 and 1 again. Please note that today's conference is being recorded. I would now like to turn the conference over to Jason Thompson, your host for today's call. Please go ahead. Thank you and good morning and welcome to the IndiVS second quarter 2025 earnings conference call. I'm joined today by Joe Schifone, Chief Executive Officer, Patrick Berry, Chief Commercial Officer, Christian Heidbreder, Chief Scientific Officer and Ryan Prebitt, our Chief Financial Officer. Before we begin I need to remind everyone that on today's call we may make forward-looking statements that are subject to risks and uncertainties and that actual results may differ materially. We list the factors that may cause our results to be materially different here on slide 2 of this presentation. We also may refer to non-GAB measures, the reconciliations for which may also be found in the appendix to this presentation that is now posted on our website IndiVir.com. I'll now turn the call over to Joe. Thanks Jason. Good morning and thank you everyone for joining the call. Today I will start with an overview of our performance in the quarter and then introduce the IndiVir action agenda. Pat will discuss the actions we are taking to generate momentum with Sublicate in the U.S. and Ryan will review the financial results for the along with our upwardly revised f...